Trump'ın danışmanı David Sacks, göreve başlamadan önce 200 milyon dolarlık kripto yatırımını elden çıkardı

Lotus BioScience Ventures

investment firm

About

Lotus BioScience Ventures finances seed, early, and mid stage companies in the biotherapeutics industry.

  • Hong Kong,Hong Kong Island,Hong Kong

Details

Operating Status
Active
Investor Type
Venture Capital

Investments

Number of Investments
Number of Lead Investments
6
0
Lotus BioScience Ventures has made 6 investments. Their most recent investment was on Sep 23, 2008, when Humanigen raised $20M.
Date Company Name
Round Money Raised Industry Lead Investor
Sep 23, 2008 Humanigen
Series D $20M Biopharma
Series D $42.60M Biotechnology
Private Equity(PE) $71.30M Biotechnology
Mar 16, 2005 Humanigen
Series B $20M Biopharma
Series B $70M Biopharma

Exits

Lotus BioScience Ventures has had 5 exits. Lotus BioScience Ventures most notable exits include Humanigen ,   Nereus Pharmaceuticals

Date Company Name Exit Type Industry
Aug 7, 2017 Humanigen IPO Biopharma Detail
Jan 1, 2012 Nereus Pharmaceuticals M&A Biotechnology Detail
Oct 17, 2011 Anadys Pharmaceuticals M&A Biotechnology Detail
Aug 4, 2009 Infinity Pharmaceuticals IPO Biopharma Detail
Feb 19, 2004 Dynavax Technologies IPO Biopharma Detail